Published in Br J Pharmacol on June 01, 1994
Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A (1996) 3.39
Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl) (2004) 1.66
Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol (2008) 1.55
Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A (1995) 1.43
Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci U S A (1999) 1.05
Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands. Br J Pharmacol (2001) 0.99
Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. Psychopharmacology (Berl) (2005) 0.92
Anti-amnesic effect of dimemorfan in mice. Br J Pharmacol (2003) 0.83
Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors. Psychopharmacology (Berl) (1997) 0.82
Pregnancy reduces brain sigma receptor function. Br J Pharmacol (1999) 0.82
Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Br J Pharmacol (1996) 0.81
Sigma receptors [σRs]: biology in normal and diseased states. J Recept Signal Transduct Res (2015) 0.78
Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. PLoS One (2012) 0.78
G proteins: transducers of receptor-generated signals. Annu Rev Biochem (1987) 27.41
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol (1983) 3.69
A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science (1986) 3.17
Glutamate stimulates inositol phosphate formation in striatal neurones. Nature (1985) 2.02
Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther (1982) 1.97
1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci U S A (1986) 1.37
Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors. Proc Natl Acad Sci U S A (1986) 1.34
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science (1977) 1.24
Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology (1977) 1.22
Effects of ketamine and three other anaesthetics on spinal reflexes and inhibitions in the cat. Br J Anaesth (1984) 1.21
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol (1990) 1.17
Excitatory amino acids inhibit stimulation of phosphatidylinositol metabolism by aminergic agonists in hippocampus. Nature (1986) 1.14
Commissural synapses, but not mossy fiber synapses, in hippocampal field CA3 exhibit associative long-term potentiation and depression. Brain Res (1989) 1.02
Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain. Eur J Pharmacol (1992) 0.99
In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther (1992) 0.97
Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents. Mol Pharmacol (1989) 0.94
Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine. J Neurochem (1989) 0.94
Characterization of subtypes of excitatory amino acid receptors involved in the stimulation of inositol phosphate synthesis in rat brain synaptoneurosomes. Eur J Pharmacol (1987) 0.93
JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites. J Pharm Pharmacol (1990) 0.90
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor. J Pharmacol Exp Ther (1992) 0.88
Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.88
Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology (1990) 0.87
Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats. Neuropharmacology (1991) 0.87
Computer-assisted modeling of multiple dextromethorphan and sigma binding sites in guinea pig brain. Eur J Pharmacol (1991) 0.86
Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors. J Pharmacol Exp Ther (1992) 0.86
Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum. J Pharmacol Exp Ther (1993) 0.85
Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res (1990) 0.84
Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Neuropsychopharmacology (1989) 0.83
Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins. J Pharmacol Exp Ther (1993) 0.82
Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats. Br J Pharmacol (1992) 0.81
Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site. Eur J Pharmacol (1990) 0.81
Comparison of the actions of phencyclidine and sigma ligands on CA1 hippocampal pyramidal neurons in the rat. Neuropharmacology (1988) 0.81
(+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo. Neuropharmacology (1991) 0.81
Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites. Eur J Pharmacol (1989) 0.81
Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation. J Neurosci (1993) 0.81
The sigma ligand 1,3-di-o-tolylguanidine depresses amino acid-induced excitation non-selectively in rat brain. Eur J Pharmacol (1992) 0.81
Effects of N-ethylmaleimide and forskolin on noradrenaline release from rat hippocampal slices. Evidence that prejunctional adenosine and alpha-receptors are linked to N-proteins but not to adenylate cyclase. Acta Physiol Scand (1987) 0.81
Failure of sigma-receptor ligands to reduce the excitatory actions of N-methyl-DL-aspartate on rat spinal neurons in-vivo. J Pharm Pharmacol (1990) 0.80
Participation of protein kinase C and regulatory G proteins in modulation of the evoked noradrenaline release in brain. Cell Mol Neurobiol (1988) 0.80
Multiple vascular effects of sigma and PCP ligands: inhibition of amine uptake and contractile responses. J Pharmacol Exp Ther (1990) 0.79
Neuropeptide Y and sigma receptor agonists act through a common pathway to stimulate duodenal alkaline secretion in rats. Eur J Pharmacol (1993) 0.79
Multiple sigma binding sites in guinea-pig and rat brain membranes: G-protein interactions. Br J Pharmacol (1992) 0.78
Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurones in vitro. Brain Res (1987) 0.78
In vivo interaction of neuropeptide Y and peptide YY with sigma receptor sites in the mouse brain. Eur J Pharmacol (1993) 0.77
The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex. Eur J Pharmacol (1993) 0.77
N-methyl-D-aspartate receptor complex modulation by neuropeptide Y and peptide YY in rat hippocampus in vitro. Neurosci Lett (1991) 0.76
Regulation of the binding of sigma- and phencyclidine (PCP)-receptor ligands in rat brain membranes by guanine nucleotides and ions. Neurosci Lett (1988) 0.76
Current advances and trends in the treatment of depression. Trends Pharmacol Sci (1994) 3.49
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A (2005) 2.96
Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A (1997) 2.50
Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol (1999) 2.44
Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci (1996) 2.22
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacology (2001) 2.00
Rhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat. Brain Res (1973) 1.96
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (2008) 1.88
Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol (1995) 1.63
Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci (1998) 1.56
Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci (1998) 1.51
Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse (1987) 1.39
Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein. Oncogene (2009) 1.35
Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology (1999) 1.30
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30
Intramuscular glycogen and intramyocellular lipid utilization during prolonged exercise and recovery in man: a 13C and 1H nuclear magnetic resonance spectroscopy study. J Clin Endocrinol Metab (2000) 1.27
Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci (1996) 1.26
The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev (1997) 1.25
Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.22
P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene (2011) 1.22
Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol (1999) 1.18
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol (1990) 1.17
Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol (1987) 1.17
Processing of the papain precursor. The ionization state of a conserved amino acid motif within the Pro region participates in the regulation of intramolecular processing. J Biol Chem (1995) 1.15
Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology (1991) 1.13
A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry (1990) 1.12
Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science (1978) 1.07
Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers. Br J Pharmacol (1999) 1.06
Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system. Br J Pharmacol (1997) 1.03
Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology (1996) 1.01
Complex formation between mycobacterial polysaccharides or cyclodextrins and palmitoyl coenzyme A. J Biol Chem (1975) 0.99
Effects of cyclodextrins on fatty acid synthesis. J Biol Chem (1973) 0.99
Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.99
Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry (1983) 0.99
Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci (1994) 0.99
Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands. Br J Pharmacol (2001) 0.99
Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones. Nature (1984) 0.98
Oestrogen and testosterone modulate the firing activity of dorsal raphe nucleus serotonergic neurones in both male and female rats. J Neuroendocrinol (2005) 0.97
In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther (1992) 0.97
Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat. Diabetologia (2012) 0.97
In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci (1986) 0.96
Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission. Neuropharmacology (1991) 0.94
Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. J Endocrinol (1996) 0.93
Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology (1997) 0.93
Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain. Eur Neuropsychopharmacol (2000) 0.93
Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol (1998) 0.93
Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biol Psychiatry (1998) 0.92
The use of pindolol to potentiate antidepressant medication. J Clin Psychiatry (1998) 0.92
Relative brain size and metabolism in birds. Brain Behav Evol (1985) 0.92
Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons. Neuropharmacology (1998) 0.92
Transportation of market-weight pigs: II. effect of season and location within truck on behavior with an eight-hour transport. J Anim Sci (2013) 0.91
Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine. Int Clin Psychopharmacol (1995) 0.91
Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands. Eur J Pharmacol (1993) 0.91
In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.90
Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment. Neuropharmacology (1984) 0.90
Effects of transport duration on maintenance behavior, heart rate and gastrointestinal tract temperature of market-weight pigs in 2 seasons. J Anim Sci (2013) 0.90
Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology (1994) 0.89
Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. J Pharmacol Exp Ther (1984) 0.89
Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. J Pharmacol Exp Ther (1991) 0.89
Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.89
Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Eur J Pharmacol (1999) 0.88
Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience (1985) 0.88
Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther (1988) 0.88
Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.88
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor. J Pharmacol Exp Ther (1992) 0.88
Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat. Psychopharmacology (Berl) (1984) 0.87
Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine. Brain Res (1988) 0.87
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Synapse (1999) 0.87
Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology (1995) 0.87
Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans. J Physiol (1999) 0.87
Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. Neuropsychopharmacology (2000) 0.86
Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. J Affect Disord (1998) 0.86
Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine. Neuropsychopharmacology (2000) 0.85
Transportation of market-weight pigs: I. effect of season, truck type, and location within truck on behavior with a two-hour transport. J Anim Sci (2013) 0.85
Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: preliminary findings. Int Clin Psychopharmacol (1996) 0.85
Domoic acid, the alleged "mussel toxin," might produce its neurotoxic effect through kainate receptor activation: an electrophysiological study in the dorsal hippocampus. Can J Physiol Pharmacol (1989) 0.85
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studies. Eur J Neurosci (1995) 0.85
Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.84
Assessment of lameness in sows using gait, footprints, postural behaviour and foot lesion analysis. Animal (2013) 0.84
Effects of season, truck type, and location within truck on gastrointestinal tract temperature of market-weight pigs during transport. J Anim Sci (2015) 0.84
Harmaline-induced rhythmic activity of cerebellar and lower brain stem neurons. Brain Res (1971) 0.83